Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine
Background: Dendritic cells (DCs) are antigen-presenting cells that play a pivotal role in adaptive cell-mediated immunity by priming and activating T cells against specific tumour and pathogenic antigens. Methotrexate (MTX), a folate derivative, functions as an immunoregulatory agent. However, the...
Main Authors: | Gao-Na Shi, Min Hu, Chengjuan Chen, Junmin Fu, Shuai Shao, Yu Zhou, Lei Wu, Tiantai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835920987056 |
Similar Items
-
Optimizing the antigen loading of dendritic cells with exogenous peptides
by: Ring B, et al.
Published: (2004-07-01) -
Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide
by: Tian Xia, et al.
Published: (2022-09-01) -
Osteopontin promotes dendritic cell maturation and function in response to HBV antigens
by: Cui GY, et al.
Published: (2015-06-01) -
Harnessing Dendritic Cells for Tumor Antigen Presentation
by: Stefan Nierkens, et al.
Published: (2011-04-01) -
Self-antigen presentation by dendritic cells in autoimmunity
by: Ann-Katrin eHopp, et al.
Published: (2014-02-01)